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Introduction
Pallister-Killian syndrome (PKS, OMIM No. 601803),
described by Pallister et al [1] and Killian et al [2], is a
rare and sporadic chromosomal anomaly with the
mosaic presence of a supernumerary tissue-limited
isochromosome 12p [i(12p)] (mosaic tetrasomy 12p)
[3]. Clinical features of postnatal PKS include men-
tal retardation, seizures, pigmentary skin lesions,
and dysmorphic facial features such as sparse ante-
rior scalp hair, hypertelorism, short nose, flat nasal
bridge, short neck and flat occiput [4]. However,
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the mosaic level of i(12p) is not correlated with the
severity of congenital anomalies [5].
Prenatal diagnosis of PKS is difficult because of
a wide range of abnormalities in fetuses with PKS
and tissue-specific distribution of i(12p). To date,
there have been more than 60 reported cases of
prenatally-diagnosed PKS. Among these cases, some
fetuses with PKS were diagnosed as an incidental
finding after karyotyping for advanced maternal
age, which is thought to be a risk factor for PKS. In
addition, ultrasound detection of fetal anomalies
could be another useful tool in the diagnosis of PKS.
We review here the associated sonographic fea-
tures in fetuses with PKS and the reported prenatal
sonographic findings including congenital diaphrag-
matic hernia (CDH), polyhydramnios, abnormal
extremities, increased nuchal translucency (NT) or
nuchal edema, cardiovascular anomalies, central
nervous system (CNS) anomalies, abnormal facial
profile, and other rare anomalies. Accurate prena-
tal diagnosis is made by the identification of i(12p)
in specific tissue samples by using appropriate ana-
lytic techniques. Fetuses of PKS can have similar struc-
tural anomalies to those of Fryns syndrome (FS) and
the differential diagnosis is discussed. Early diag-
nosis of PKS is important for genetic counseling
and obstetric management.
Prenatal Sonographic Features
Gilgenkrantz et al [6] reported the first case of pre-
natally detected PKS based on abnormal sono-
graphic findings. Currently, ultrasound is thought
to be a valuable tool in the prenatal detection of
characteristic findings associated with PKS. Prenatal
sonographic features of published PKS cases are sum-
marized in Table 1 [5–43]. Prenatally diagnosed PKS
cases without abnormal sonographic reports were
excluded in this review.
Congenital diaphragmatic hernia
Identification of abdominal organs in the chest indi-
cates CDH. Left-sided CDH is more common and typ-
ically characterized by the heart and the mediastinum
deviated to the right side, and the possible presence
of a gastric bubble or bowel peristalsis in the chest.
Right-sided CDH is more difficult to diagnose be-
cause of the similar echogenicity between the lung
and a herniated liver on prenatal ultrasound. Doppler
study of the umbilical vein or hepatic vessels and
visualization of the gall bladder may be helpful for
diagnosis of CDH. Prenatal ultrasound can detect
CDH as early as 15 weeks [44]. In Table 1 [5–43], 27
fetuses with PKS had CDH, a condition highly spe-
cific and frequently found in PKS, diagnosed pre-
natally. The occurrence of CDH might be the major
cause of perinatal or postnatal death of PKS due to
lung hypoplasia [13]. Several reports have shown
that only 10–15% of PKS cases have CDH [18,45,46].
However, Mowery-Rushton et al [26] suggested
that 50% or more of PKS cases might have CDH
due to undiagnosed and lethal cases with PKS. 
Polyhydramnios
Table 1 shows 25 fetuses with PKS that had poly-
hydramnios, also the most consistent ultrasound
finding. The reason for the development of polyhy-
dramnios in association with PKS is unknown, but
it may be associated with the presence of CDH due
to inappropriate swallowing of amniotic fluid [25].
Only one fetus with PKS was reported to have
oligohydramnios accompanied by short femurs,
cerebral ventriculomegaly and intrauterine growth
restriction.
Abnormal extremities
Micromelia is the main feature suggestive of PKS,
especially the shortness of the femurs and humerus.
As shown in Table 1, prenatal ultrasound has de-
tected rhizomelic micromelia or short femurs in 19
fetuses of PKS. In addition to micromelia, other skele-
tal anomalies such as bilateral talipes, club feet, club
hands and clenched hands have been observed in
fetuses of PKS.
Increased NT or nuchal edema
Fetal NT refers to the sonographic finding of a sub-
cutaneous collection of fluid behind the fetal neck
in the first trimester. Increased NT is significantly
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associated with chromosomal abnormalities [47].
Increased NT, nuchal edema or hygroma coli have
been reported in 12 fetuses with PKS (Table 1
[5–43]). Among these cases, five had CDH and
three had cardiovascular anomalies, but four had no
detectable cardiac anomalies or CDH. The mecha-
nism of increased NT in PKS is unknown, but the
simultaneous presence of cardiac anomalies and/or
a diaphragmatic hernia has been considered a pos-
sible cause [48,49].
Cardiovascular anomalies
Only eight fetuses with PKS have been found with
cardiovascular defects (Table 1 [5–43]). Various
anomalies have been reported including Ebstein’s
anomaly, double outlet right ventricle, atrioventric-
ular septal defect, hypoplastic left heart, tetralogy
of Fallot, right ventricular hypertrophy, ventricular
septal defects, tricuspid regurgitation and pulmonic
stenosis. All of the PKS fetuses with cardiac anom-
alies also have other structural anomalies. Therefore,
cardiac anomalies might not be the only feature
for prenatal diagnosis of PKS.
CNS anomalies
Ten fetuses with PKS have been found with CNS
anomalies including ventriculomegaly, agenesis of
the vermis, cerebellar hypoplasia, enlarged cisterna
magna, cervical spina bifida, lemon sign, and Dandy-
Walker malformation (Table 1 [5–43]). Among these
features, ventriculomegaly is the most common.
Abnormal facial profile
Abnormal facial features are the main manifesta-
tions of postnatal PKS cases including sparse ante-
rior scalp hair, hypertelorism, short nose, flat nasal
bridge, short neck and flat occiput. Ten fetuses
with PKS were found to have an abnormal facial
profile including hypertelorism, flat face, abnormal
ears, frontal bossing, small nose, thin lip with pro-
truding lower lip, retrognathia, long philtrum, and
turned up nose (Table 1 [5–43]). Paladini et al [32]
first described the typical facial abnormalities, includ-
ing a small nose and a thin upper lip with a protrud-
ing lower lip, in a fetus with PKS on mid-trimester
ultrasound. They believed that the diagnosis of PKS
should be considered when the above typical facial
features were present in fetuses with diaphragmatic
hernia and short limbs. Sananes et al [42] reported
that a 3D examination of the fetal face may be
useful for diagnosing PKS.
Rare anomalies
Chen [50] reported that omphalocele was found
in cases of PKS with mosaic tetrasomy 12p. Three
PKS fetuses with omphalocele have also been found
with other anomalies such as polyhydramnios, rhi-
zomelic micromelia, cystic hygroma and CDH
(Table 1 [5–43]). Fetal overgrowth has been observed
in three cases of PKS. Zollino et al [30] speculated
that unexplained fetal overgrowth could be an indi-
cator for karyotypic analysis. However, being small
for gestational age and intrauterine fetal growth
restriction are also distinct findings reported in
several fetuses of PKS (Table 1). Fetal hydrops asso-
ciated with PKS is not common but it has been
reported in five fetuses (Table 1). The mechanism
of fetal hydrops is thought to be associated with
other anomalies such as fetal cardiac defects and
CDH [31]. The least common reported features
include hydronephrosis, ambiguous genitalia, a sin-
gle umbilical artery, echogenic bowel and hypoplas-
tic stomach (Table 1).
Molecular Cytogenetic Analysis
PKS is diagnosed with the cytogenetic presence of
an extra i(12p) in tissue-limited mosaicism. Based
on traditional G-banded analysis, it is difficult to dif-
ferentiate the extra i(12p) from inv dup 21q (tetra-
somy 21q) [14,51–53]. The addition of targeted
fluorescence in situ hybridization using chromo-
some 12-specific DNA probes [14,29] or other
molecular genetic analyses such as micro-satellites
and comparative genomic hybridization are useful
adjuncts to making an accurate diagnosis.
The mosaic level of i(12p) varies in different tis-
sue samples [54]. The i(12p) can be easily identi-
fied in cell cultures from skin fibroblasts, chorionic
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villous cells and amniocytes, but it is rarely detected
in rapidly growing cells such as peripheral blood
lymphocytes or cord blood [28,29]. In addition, a
dramatic decrease in mosaic i(12p) levels has been
observed after subculture or long-term cultures of
various fetal tissues such as blood lymphocytes,
amniocytes, chorionic villi and fibroblasts [16,55].
It is important to select the appropriate samples and
culture types for karyotypic analysis with implica-
tions for prenatal and postnatal diagnosis (Table 1
[5–43]). Interphase fluorescence in situ hybridiza-
tion can remove the need for cell culture to easily
detect the signal of i(12p) [14,21]. Currently, array
comparative genomic hybridization based on ge-
nomic DNA extracted directly from uncultured blood
cells can efficiently identify this mosaic i(12p) [56].
The origin and mechanism of formation of i(12p)
have been studied previously [57,58]. Parental study
of i(12p) has shown that most cases with PKS are of
maternal origin and are related to advanced mater-
nal age, which is considered as the main factor for
isochromosome formation [35,59]. Either a prezy-
gotic origin or a postzygotic origin of i(12p) has
been proposed [35,60–62]. As there is no difference
between PKS phenotypes of paternal origin i(12p)
and those of maternal origin i(12p), therefore, PKS
is not considered a genomic imprinting disorder
[5,23,24,60].
Differential Diagnosis
Fetuses with PKS can have CDH, polyhydramnios, ab-
normal extremities, increased NT or nuchal edema,
cardiovascular anomalies, CNS anomalies, abnor-
mal facial profile and other rare anomalies. Because
of these common anomalies in PKS, differential
diagnosis should include FS, the manifestations of
which include CDH, lung hypoplasia, distal limb hy-
poplasia, polyhydramnios, craniofacial anomalies,
cardiac defects and internal malformations [63–65].
FS is an autosomal recessive disorder and is usually
lethal. The recurrence risk is higher in FS than 
in PKS. Structural anomalies such as CDH, polyhy-
dramnios and cardiac anomalies can be detected
in both syndromes but dysmorphic facial features
are different. Micrognathia and cleft lip/palate are
commonly seen in FS, but hypertelorism, small nose,
flat and broad nasal root, and thin upper lip with a
protruding lower lip are often seen in PKS [32].
Clinically, ultrasound detection of the different facial
features can distinguish between these two syn-
dromes but it is difficult to clearly visualize the dif-
ference in early pregnancy. Hence, molecular and
cytogenetic demonstration of mosaic i(12p) on
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Table 2. Prenatal sonographic features and differential
diagnosis of Pallister-Killian syndrome
Prenatal sonographic features
Congenital diaphragmatic hernia
Polyhydramnios
Abnormal extremities
Rhizomelic micromelia, club feet, club hands,
clenched hands and talipes
Increased nuchal translucency, nuchal edema or cystic
hygroma
Cardiovascular anomalies
Ebstein’s anomaly, double outlet right ventricle,
atrioventricular septal defect, hypoplastic left heart,
tetralogy of Fallot, right ventricular hypertrophy,
ventricular septal defects, tricuspid regurgitation and
pulmonic stenosis
Central nervous system anomalies
Ventriculomegaly, agenesis of the vermis, cerebellar
hypoplasia, enlarged cisterna magna, cervical spina
bifida, a lemon sign, and Dandy-Walker
malformation
Abnormal facial profile
Hypertelorism, flat face, abnormal ears, frontal
bossing, small nose, thin lip and protruding lower lip,
retrognathia, long philtrum and turned up nose
Rare anomalies
Omphalocele, fetal hydrops, macrosomia, born small
for gestational age, intrauterine fetal growth
restriction, hydronephrosis, hypoplastic stomach,
ambiguous genitalia, echogenic bowel and single
umbilical artery
Differential diagnosis
Fryns syndrome
prenatal tissue samples is still required to make a
definite diagnosis of PKS.
Conclusion
The present article provides an overview of prena-
tal sonographic features of PKS. Prenatal detection
of CDH, polyhydramnios, rhizomelic micromelia,
increased NT or nuchal edema, cardiac anomalies,
CNS anomalies, abnormal facial profile and other
rare anomalies should alert clinicians to the possi-
bility of PKS (Table 2). Recognition of these con-
genital anomalies in association with PKS may lead
to the selection of appropriate tissue samples for
chromosome analysis because mosaic i(12p) might
only be identified in specific tissues by selective mo-
lecular cytogenetic analyses. If the traditional cyto-
genetic result is normal but prenatal sonographic
findings remain suggestive for PKS, alternative tis-
sue samples or additional diagnostic tools should be
available for further study. FS having phenotypic
overlap with PKS should be differentiated. Accurate
diagnosis of fetuses with PKS could be beneficial
for genetic counseling and clinical management.
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